BlackRock’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$778K Buy
155,899
+22,173
+17% +$111K ﹤0.01% 4268
2025
Q1
$1.07M Buy
133,726
+491
+0.4% +$3.93K ﹤0.01% 4123
2024
Q4
$990K Buy
133,235
+132,906
+40,397% +$987K ﹤0.01% 4172
2024
Q3
$3.13K Hold
329
﹤0.01% 5035
2024
Q2
$4.1K Sell
329
-1,795
-85% -$22.4K ﹤0.01% 5093
2024
Q1
$46.2K Sell
2,124
-13,752
-87% -$299K ﹤0.01% 4827
2023
Q4
$144K Buy
15,876
+15,440
+3,541% +$141K ﹤0.01% 4643
2023
Q3
$12.6K Sell
436
-83
-16% -$2.41K ﹤0.01% 5117
2023
Q2
$44.2K Buy
519
+89
+21% +$7.58K ﹤0.01% 4995
2023
Q1
$180K Hold
430
﹤0.01% 4721
2022
Q4
$520K Sell
430
-1
-0.2% -$1.21K ﹤0.01% 4513
2022
Q3
$343K Sell
431
-1
-0.2% -$796 ﹤0.01% 4739
2022
Q2
$622K Sell
432
-876
-67% -$1.26M ﹤0.01% 4610
2022
Q1
$2.73M Sell
1,308
-12
-0.9% -$25K ﹤0.01% 4179
2021
Q4
$6.46M Buy
1,320
+29
+2% +$142K ﹤0.01% 3821
2021
Q3
$8.1M Buy
1,291
+11
+0.9% +$69K ﹤0.01% 3710
2021
Q2
$12.1M Buy
1,280
+444
+53% +$4.18M ﹤0.01% 3518
2021
Q1
$7.27M Buy
836
+129
+18% +$1.12M ﹤0.01% 3698
2020
Q4
$5.37M Buy
707
+20
+3% +$152K ﹤0.01% 3608
2020
Q3
$4.5M Buy
687
+86
+14% +$564K ﹤0.01% 3532
2020
Q2
$4.5M Buy
601
+158
+36% +$1.18M ﹤0.01% 3492
2020
Q1
$3.16M Sell
443
-6
-1% -$42.8K ﹤0.01% 3452
2019
Q4
$6.97M Buy
449
+14
+3% +$217K ﹤0.01% 3361
2019
Q3
$4.12M Buy
435
+16
+4% +$152K ﹤0.01% 3495
2019
Q2
$6.56M Buy
419
+409
+4,090% +$6.4M ﹤0.01% 3399
2019
Q1
$170K Sell
10
-2
-17% -$34K ﹤0.01% 4218
2018
Q4
$109K Buy
12
+2
+20% +$18.2K ﹤0.01% 4294
2018
Q3
$133K Hold
10
﹤0.01% 4339
2018
Q2
$120K Buy
10
+9
+900% +$108K ﹤0.01% 4381
2018
Q1
$16K Hold
1
﹤0.01% 4542
2017
Q4
$12K Hold
1
﹤0.01% 4557
2017
Q3
$3K Hold
1
﹤0.01% 4721
2017
Q2
$2K Hold
1
﹤0.01% 4819
2017
Q1
$2K Buy
+1
New +$2K ﹤0.01% 4818